uMed: London based healthtech expands into US market via seven-figure funding round

uMed, a health and research technology company, has raised £9.8m in its latest venture capital funding round, which it will use to boost participation in clinical trials. The raise is backed by Delin Ventures, AlbionVC, Playfair Capital and Silicon Valley's 11.2 Capital. The UK is reportedly facing a collapse in industry... Read more